Literature DB >> 19124099

Contrast enhancement in chest multidetector computed tomography: intraindividual comparison of 300 mg/ml versus 400 mg/ml iodinated contrast medium.

Florian F Behrendt1, Cedric Plumhans, Sebastian Keil, Georg Mühlenbruch, Marco Das, Peter Seidensticker, Christina Mutscher, Rolf W Günther, Andreas H Mahnken.   

Abstract

RATIONALE AND
OBJECTIVES: We sought to intraindividually compare intravascular contrast enhancement in multidector computed tomography (MDCT) of the chest using contrast media (CM) containing 300 and 400 mg iodine/ml.
MATERIALS AND METHODS: Seventy-one patients underwent repeated MDCT scanning of the chest at baseline and follow-up. CM with standard iodine (protocol A: 300 mg iodine/ml; Iopromide 300) and high iodine concentration (protocol B: 400 mg iodine/ml; Iomeprol 400) were used. The iodine delivery rate (1.29 g iodine/s) and total iodine load (37 g iodine) were identical for the two protocols. Contrast enhancement was measured in the right and left ventricles, pulmonary trunk, right and left pulmonary arteries, and ascending and descending aortas. Results were compared using paired t-tests; P values were adjusted using Bonferroni correction (P <or= .005).
RESULTS: Contrast enhancement values showed no statistically significant differences between the two protocols at all anatomic sites (all P > .005). In the right ventricle, pulmonary trunk, and right and left pulmonary arteries, higher attenuation values for protocol A were detected compared to protocol B (379.0 +/- 110.5 vs. 349.8 +/- 117.6, 354.5 +/- 112.2 vs 330.9 +/- 118.3, 348.6 +/- 106.0 vs. 321.8 +/- 109.9, and 347.9 +/- 102.4 vs. 321.0 +/- 104.9 HU, respectively). After the lung circulation (left ventricle, ascending aorta, and descending aorta), attenuation values were marginally higher for protocol B. Using both protocols resulted in suitable contrast enhancement with a mean pulmonary attenuation higher than 300 HU.
CONCLUSIONS: Using an adapted injection protocol, the administration of 300 and 400 mg iodine CM resulted in a suitable intravascular contrast enhancement in the chest. The use of 400 mg iodine CM does not lead to a statistically significant improvement in contrast enhancement compared to the 300 mg iodine CM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124099     DOI: 10.1016/j.acra.2008.05.008

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

1.  Intra-individual comparison of different contrast media concentrations (300 mg, 370 mg and 400 mg iodine) in MDCT.

Authors:  Florian F Behrendt; Hubertus Pietsch; Gregor Jost; Martin A Sieber; Sebastian Keil; Cedric Plumhans; Peter Seidensticker; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

2.  Contrast medium injection protocol adjusted for body surface area in combined PET/CT.

Authors:  Florian F Behrendt; Marilou Rebière; Andreas Goedicke; Hubertus Pietsch; Karin Palmowski; Christiane K Kuhl; Felix M Mottaghy; Frederik A Verburg
Journal:  Eur Radiol       Date:  2013-02-20       Impact factor: 5.315

3.  Biphasic contrast medium injection in cardiac CT: moderate versus high concentration contrast material at identical iodine flux and iodine dose.

Authors:  Annemarieke Rutten; Matthijs F L Meijs; Alexander M de Vos; Peter R Seidensticker; Mathias Prokop
Journal:  Eur Radiol       Date:  2010-03-20       Impact factor: 5.315

4.  Pulmonary 64-MDCT angiography with 50 mL of iodinated contrast material in an unselected patient population: a feasible protocol.

Authors:  Henrique Simão Trad; Gustavo Santos Boasquevisque; Tiago Rangon Giacometti; Catherine Yang Trad; Orlando Salomão Zoghbi Neto; Clovis Simão Trad
Journal:  Radiol Bras       Date:  2016 Mar-Apr

5.  Split-Bolus Single-Pass Multidetector-Row CT Protocol for Diagnosis of Acute Pulmonary Embolism.

Authors:  Michele Scialpi; Alberto Rebonato; Lucio Cagini; Luca Brunese; Irene Piscioli; Luisa Pierotti; Lucio Bellantonio; Alfredo D'Andrea; Antonio Rotondo
Journal:  Iran J Radiol       Date:  2016-01-14       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.